Oncology & Hematology Coding Alert

Coding Strategy:

Doctor Prescribing Venetoclax for CLL Patients? Here's What to Submit

Keep documentation for patient selection and any prior treatment. Have you been coding accurately for venetoclax? On April 11, 2016, the FDA approved venetoclax (Venclexta; Janssen) tablets for the treatment of patients of chronic lymphocytic leukemia (CLL) with depletion of 17p chromosome. When to use venetoclax: Your physician will prescribe venetoclax when: The detection of chromosome 17p deletion is established [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All